Illinois · House Bill 5405 · 103rd General Assembly

DIVERSITY IN CLINICAL TRIALS

  1. Introduced Feb 9, 2024
  2. In committee Feb 9, 2024
  3. Passed the House Apr 19, 2024
  4. Passed the Senate May 16, 2024
  5. To the governor Jun 21, 2024
  6. Became law Aug 9, 2024

What it does

The legislature's own summary of the bill, or its official long title.

Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Sets forth requirements for any State entity or hospital that receives funding from the National Institutes of Health to conduct clinical trials of drugs or medical devices. Provides that the Department of Public Health, in consultation with relevant research organizations, shall analyze and provide…

Read the full title (229 words)

Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Sets forth requirements for any State entity or hospital that receives funding from the National Institutes of Health to conduct clinical trials of drugs or medical devices. Provides that the Department of Public Health, in consultation with relevant research organizations, shall analyze and provide recommendations on: (i) the demographic groups and populations that are currently represented and underrepresented in clinical trials in the State, including representation of groups based on their geographic location; (ii) the barriers that prevent persons who are members of underrepresented demographic groups from participating in clinical trials in the State, including barriers related to transportation; and (iii) approaches for how clinical trials can successfully partner with others to provide outreach to underrepresented communities. Provides that the Department shall report to the General Assembly on the results of the study by July 1, 2025. Sets forth definitions of underrepresented community and underrepresented demographic group. Provides that the Department shall review guidance published by the United States Food and Drug Administration and use existing infrastructure to encourage participation in clinical trials of drugs and medical devices by persons who are members of underrepresented demographic groups. Authorizes the Department to apply for any grants related to the encouragement of underrepresented demographic groups related to the United Food and Drug Administration's guidance.

Every action

63 steps, oldest first, as the legislature records them.

Show the 55 earlier steps
  1. HouseFiled with the Clerk by Rep. Marcus C. Evans, Jr.
  2. HouseFirst Reading
  3. CommitteeReferred to Rules Committee · House Rules
  4. CommitteeAssigned to Public Health Committee · House Public Health
  5. CommitteeDo Pass / Short Debate Public Health Committee; 009-000-000 · House Public Health
  6. HouseAdded Co-Sponsor Rep. Yolonda Morris
  7. HouseAdded Co-Sponsor Rep. Theresa Mah
  8. HousePlaced on Calendar 2nd Reading - Short Debate
  9. HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Marcus C. Evans, Jr.
  10. CommitteeHouse Floor Amendment No. 1 Referred to Rules Committee · House Rules
  11. HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  12. HouseRemoved Co-Sponsor Rep. Camille Y. Lilly
  13. HouseAdded Chief Co-Sponsor Rep. Eva-Dina Delgado
  14. HouseAdded Co-Sponsor Rep. Robert "Bob" Rita
  15. CommitteeHouse Floor Amendment No. 1 Rules Refers to Public Health Committee · House Public Health
  16. CommitteeHouse Floor Amendment No. 1 Recommends Be Adopted Public Health Committee; 007-000-000 · House Public Health
  17. HouseSecond Reading - Short Debate
  18. HouseHeld on Calendar Order of Second Reading - Short Debate
  19. HouseAdded Co-Sponsor Rep. Anne Stava-Murray
  20. HouseAdded Co-Sponsor Rep. Kevin John Olickal
  21. HouseHouse Floor Amendment No. 1 Adopted
  22. HousePlaced on Calendar Order of 3rd Reading - Short Debate
  23. HouseThird Reading - Short Debate - Passed 100-006-000
  24. HouseAdded Co-Sponsor Rep. Cyril Nichols
  25. SenateArrive in Senate
  26. SenatePlaced on Calendar Order of First Reading
  27. SenateChief Senate Sponsor Sen. Julie A. Morrison
  28. SenateFirst Reading
  29. CommitteeReferred to Assignments · Senate Assignments
  30. CommitteeAssigned to Public Health · Senate Public Health
  31. SenateRule 2-10 Committee Deadline Established As May 10, 2024
  32. SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Julie A. Morrison
  33. CommitteeSenate Committee Amendment No. 1 Referred to Assignments · Senate Assignments
  34. CommitteeSenate Committee Amendment No. 1 Assignments Refers to Public Health · Senate Public Health
  35. SenateSenate Committee Amendment No. 1 Adopted
  36. SenateAdded as Alternate Co-Sponsor Sen. Mary Edly-Allen
  37. CommitteeDo Pass as Amended Public Health; 008-000-000 · Senate Public Health
  38. SenatePlaced on Calendar Order of 2nd Reading May 9, 2024
  39. SenateAdded as Alternate Chief Co-Sponsor Sen. Mattie Hunter
  40. SenateSecond Reading
  41. SenatePlaced on Calendar Order of 3rd Reading
  42. SenateThird Reading - Passed; 057-001-000
  43. HouseArrived in House
  44. HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 1
  45. HouseAdded Co-Sponsor Rep. La Shawn K. Ford
  46. HouseRemoved Co-Sponsor Rep. La Shawn K. Ford
  47. HouseSenate Committee Amendment No. 1 Motion Filed Concur Rep. Marcus C. Evans, Jr.
  48. CommitteeSenate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee · House Rules
  49. CommitteeSenate Committee Amendment No. 1 Motion to Concur Rules Referred to Public Health Committee · House Public Health
  50. CommitteeSenate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Public Health Committee; 008-000-000 · House Public Health
  51. HouseAdded Chief Co-Sponsor Rep. Camille Y. Lilly
  52. HouseAdded Chief Co-Sponsor Rep. Kimberly Du Buclet
  53. HouseSenate Committee Amendment No. 1 House Concurs 105-000-000
  54. HouseHouse Concurs
  55. HousePassed Both Houses
  1. HouseAdded Co-Sponsor Rep. Joyce Mason
  2. HouseAdded Co-Sponsor Rep. Sharon Chung
  3. SenateAdded as Alternate Co-Sponsor Sen. Doris Turner
  4. SenateAdded as Alternate Co-Sponsor Sen. Adriane Johnson
  5. HouseSent to the Governor
  6. HouseGovernor Approved
  7. HouseEffective Date January 1, 2025
  8. HousePublic Act . . . . . . . . . 103-0860

Roll calls

8 recorded votes: 3 on the floor, 5 in committee. Each shows how every member voted.

Third Reading · Full House

Passed 100–6
Apr 19, 2024 · journal entry
Yes 100 No 6 Not voting 12
Democrats: 68 yes, 0 no Republicans: 32 yes, 6 no
How each member voted

Yes · 100

No · 6

Not voting · 1

Absent · 1

Excused · 10

Third Reading · Full Senate

Passed 57–1
May 16, 2024 · journal entry
Yes 57 No 1 Not voting 1
Democrats: 40 yes, 0 no Republicans: 17 yes, 1 no
How each member voted

Yes · 57

No · 1

Not voting · 1

Senate Committee Amendment No. 1 - Concurrence · Full House

Passed 105–0
May 25, 2024 · journal entry
Yes 105 No 0 Not voting 12
Democrats: 70 yes, 0 no Republicans: 35 yes, 0 no
How each member voted

Yes · 105

Not voting · 2

Excused · 10

Committee and other votes

DateWhereQuestionResult
Apr 4, 2024 House Public Health Public Health - Do Pass
Members

Yes · 9

Passed 9–0
Apr 16, 2024 House Public Health House Floor Amendment No. 1 - Public Health - Recommends Be Adopted
Members

Yes · 7

Not voting · 2

Passed 7–0
May 7, 2024 Senate Public Health Public Health - Do Pass As Amended
Members

Yes · 8

8–0
May 7, 2024 Senate Public Health Senate Committee Amendment No. 1 - Public Health - Be Adopted
Members

Yes · 8

8–0
May 22, 2024 House Public Health Senate Committee Amendment No. 1 - Public Health - Recommends Be Adopted
Members

Yes · 8

Not voting · 1

Passed 8–0

Sponsors

The member who introduced it, joined by 15 cosponsors: 15 Democrats.

All 15 cosponsors

From Illinois's official records (www.ilga.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.